This study delineates a comprehensive landscape of 3447 lung squamous cell carcinoma (LUSC)‐specific oncogenic enhancers (SOEs), unveiling their pivotal role in driving tumor pathogenesis through enrichment of key transcription factors, including SOX2, p63, KLF5, and GRHL2. This evidence concerns the gene TP63 and squamous cell lung carcinoma.